As of 2025-08-04, the Relative Valuation of Shandong Buchang Pharmaceuticals Co Ltd (603858.SS) is (5.91) CNY. This relative valuation is based on P/E multiples. With the latest stock price at 18.38 CNY, the upside of Shandong Buchang Pharmaceuticals Co Ltd based on Relative Valuation is -132.1%.
The range of the Relative Valuation is (5.72) - (5.66) CNY.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.6x - 24.2x | 21.0x |
| Forward P/E multiples | 13.7x - 17.4x | 15.2x |
| Fair Price | (5.72) - (5.66) | (5.91) |
| Upside | -131.1% - -130.8% | -132.1% |
| Date | P/E |
| 2025-08-01 | -56.38 |
| 2025-07-31 | -55.80 |
| 2025-07-30 | -56.38 |
| 2025-07-29 | -56.66 |
| 2025-07-28 | -55.77 |
| 2025-07-25 | -55.37 |
| 2025-07-24 | -55.25 |
| 2025-07-23 | -54.82 |
| 2025-07-22 | -55.00 |
| 2025-07-21 | -54.85 |
| 2025-07-18 | -54.94 |
| 2025-07-17 | -55.19 |
| 2025-07-16 | -54.63 |
| 2025-07-15 | -54.60 |
| 2025-07-14 | -52.89 |
| 2025-07-11 | -51.78 |
| 2025-07-10 | -51.57 |
| 2025-07-09 | -50.83 |
| 2025-07-08 | -50.74 |
| 2025-07-07 | -50.83 |
| 2025-07-04 | -50.98 |
| 2025-07-03 | -50.59 |
| 2025-07-02 | -50.09 |
| 2025-07-01 | -50.00 |
| 2025-06-30 | -49.82 |
| 2025-06-27 | -49.57 |
| 2025-06-26 | -49.57 |
| 2025-06-25 | -49.94 |
| 2025-06-24 | -49.73 |
| 2025-06-23 | -48.93 |
| 2025-06-20 | -48.87 |
| 2025-06-19 | -48.78 |
| 2025-06-18 | -49.14 |
| 2025-06-17 | -50.00 |
| 2025-06-16 | -50.34 |
| 2025-06-13 | -50.77 |
| 2025-06-12 | -51.66 |
| 2025-06-11 | -51.41 |
| 2025-06-10 | -51.69 |
| 2025-06-09 | -51.69 |
| 2025-06-06 | -50.62 |
| 2025-06-05 | -50.68 |
| 2025-06-04 | -51.38 |
| 2025-06-03 | -51.60 |
| 2025-05-30 | -51.23 |
| 2025-05-29 | -50.68 |
| 2025-05-28 | -49.88 |
| 2025-05-27 | -49.85 |
| 2025-05-26 | -48.93 |
| 2025-05-23 | -49.48 |